-+ 0.00%
-+ 0.00%
-+ 0.00%

NOVO NORDISK'S DENECIMIG (MIM8) DEMONSTRATED POSITIVE RESULTS IN LONG TERM SAFETY AND EFFICACY IN PHASE 3 HEMOPHILIA A FRONTIER EXTENSION STUDY AT ISTH 2026

Reuters·07/11/2026 12:05:01

Please log in to view news